(RDUS) - Earnings & Price History

RDUS: - 30.98, $1.42B, -1.13 (-3.52%)

Sector: Healthcare - Industry: Biotechnology

Radius Health, Inc., a biopharmaceutical company, develops and sells therapeutics in the areas of osteoporosis, oncology, and endocrine diseases primarily in the United States. Its product candidates include Abaloparatide-SC, a novel synthetic peptide analog of parathyroid hormone-related protein, which has been completed Phase III clinical development for the treatment of patients with postmenopausal osteoporosis; and Abaloparatide-TD, a transdermal patch that has been completed Phase II clinical trial, which is used as a short wear-time transdermal patch. The company is also involved in developing RAD1901, a selective estrogen receptor down-regulator/degrader, which is in Phase I clinical trial for the treatment of metastatic breast cancer and other estrogen receptor mediated oncology applications, as well as in Phase IIb clinical trial for the treatment of postmenopausal vasomotor sym

Past RDUS reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-02-23-1.3441.0543.1941.740.6142.62-3.45%-1.56%-4.95%930.63K
2016-11-03BMO-1.0336.839.5639.5335.9239.77-0.08%-6.91%-6.98%2.02M
2016-08-04BMO-0.9550.555353.2950.2253.290.55%▲-5.14%-4.62%2.16M
2016-05-05BMO-0.7430.4933.043330.2533-0.12%-7.61%-7.72%1.09M
2016-02-25BMO-0.6430.9233.0432.130.833.81-2.85%-3.68%-6.42%1.69M
2015-11-1762.3261.5163.8161.1365.983.74%-2.34%1.32%1.49M
2015-11-05-0.5770.8171.9571.970.5174.25-0.07%-1.52%-1.58%1.05M
2015-08-06-0.5266.5368.4468.7163.468.970.39%▲-3.17%-2.79%1.07M
2015-05-06-0.5236.7437.5838.5736.5438.732.63%-4.74%-2.24%168.91K
2014-11-11BMORadius Health-1.46-0.5920.6622.3222.319.2822.96-0.09%-7.35%-7.44%117.00K
2014-08-12BMORadius Health-0.54-2.2212.512.6412.5711.6112.65-0.55%▲-0.56%-1.11%53.70K

Login | Register
Saturday Aug 18, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades